molecules of the month

E7766 (STING)

intratumoral STING receptor agonist

in Ph. I for adv. solid tumors as single agent

from macrocyclization of cyclic dinucleotide

ChemMedChem., Jan. 31, 2021

Eisai Inc., Cambridge, MA

Chemical structure of molecule E7766 sting agonist
1 min read

3. The Eisai STING agonist E7766 leads to tumor eradication in 9/10 treated animals in a syngeneic model when injected intratumorally, and is currently in a Ph. I study for advanced solid tumors. The molecule has an interesting macrocyclic structure, and behaves as a cyclic dinucleotide mimic with potent activity on all four human STING variants.

request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.

already a member? log in: